Prestige Consumer Healthcare
248 hedge funds and large institutions have $2.85B invested in Prestige Consumer Healthcare in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 82 increasing their positions, 92 reducing their positions, and 13 closing their positions.
169% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 13
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
9% more funds holding
Funds holding: 228 → 248 (+20)
5% more capital invested
Capital invested by funds: $2.7B → $2.85B (+$143M)
2.41% less ownership
Funds ownership: 103.79% → 101.39% (-2.4%)
11% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 92
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $501K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Burney Company
Reston,
Virginia
|
+$11.4M |
| 2 |
Millennium Management
New York
|
+$11.2M |
| 3 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$9.31M |
| 4 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$8.24M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$5.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$55.9M |
| 2 |
TCAM
Turtle Creek Asset Management
Toronto,
Ontario, Canada
|
-$24.8M |
| 3 |
Goldman Sachs
New York
|
-$22.3M |
| 4 |
BlackRock
New York
|
-$12.5M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.82M |
PBH Hedge Fund Activity: Q3 2021 in Review
248 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2021, worth a combined $2.85B — up 5.3% from $2.7B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new PBH positions and 13 closed out — a net gain of 22 holders — while 82 added to existing stakes and 92 trimmed.
The largest buyer was Burney Company, adding an estimated $11.4M. The largest seller was Champlain Investment Partners, cutting an estimated $55.9M.
- 248 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2021, up from 228 in Q2 2021.
- Funds reported $2.85B of Prestige Consumer Healthcare stock for Q3 2021, up 5.3% quarter-over-quarter.
- 35 funds opened new Prestige Consumer Healthcare positions in Q3 2021 and 13 closed out, a net change of +22 holders.
- The largest Prestige Consumer Healthcare buyer in Q3 2021 was Burney Company, an estimated $11.4M added.
- The largest Prestige Consumer Healthcare seller in Q3 2021 was Champlain Investment Partners, an estimated $55.9M sold.
Based on aggregated 13F filings for Q3 2021.